LCM
ACHN

Laurion Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Laurion Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-389,300
Closed -$4.77M – 496
2014
Q4 		$4.77M Buy
+389,300
New +$4.75M 0.11% 90

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Laurion Capital Management's ACHN Position: Q4 2015 in Review

Laurion Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2015, closing a stake of 112,032 shares — an estimated $774K sold.

Laurion Capital Management first reported a position in ACHN in Q4 2014 and held it in 4 quarters. The position peaked at $8.37M in Q4 2014. 152 funds tracked by Wall St. Rank hold ACHN as of Q4 2015.

  • Laurion Capital Management reported no remaining Achillion Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Laurion Capital Management sold 112,032 Achillion Pharmaceuticals shares in Q4 2015, an estimated $774K.
  • Laurion Capital Management first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Laurion Capital Management's Achillion Pharmaceuticals position peaked at $8.37M in Q4 2014.
  • 152 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2015.

Based on Laurion Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.